Tuesday's After-Hours Movers Led By Akebia, Tetraphase, Pep Boys & TiVo

Shares of Pep Boys-Manny Moe and Jack PBY, which rose 2.36 percent Tuesday, were down slightly after hours.

The small-cap service and automotive aftermarket company reported earnings of $0.09 per share, in line with the Street’s consensus estimate, on below-consensus revenue of $526.55 million (the Street was expecting sales of $529.58 million).

TiVo Inc. TIVO was rising on its earnings report. After gaining 2.82 percent during the day, the stock rose another 1.1 percent after the bell, to $9.20.

TiVo delivered second-quarter earnings of $0.11 per share on revenue of $119.45 million, above the Street’s consensus, which called for EPS of $0.09 on sales of $117.56 million, and considerably surpassing the high end of the management’s guidance for revenue of $97 million.

Akebia Therapeutics Inc AKBA rose more than 60 percent after announcing positive top-line results from a Phase 2 study of Vadadustat “in Dialysis Patients with Anemia Related to Chronic Kidney Disease.”

On the opposite side, Tetraphase Pharmaceuticals Inc TTPH lost about 80 percent after failing to meet the primary endpoint of statistical non-inferiority for IGNITE2, compared to levofloxacin.

Vitae Pharmaceuticals Inc VTAE rose more than 34 percent, after making public the positive top-line results it achieved “from its Phase 1 single ascending dose clinical study of VTP-43742 in autoimmune disorders.”

Flexion Therapeutics Inc FLXN plummeted about 43 percent after failing to demonstrate statistical significance for the primary endpoint for FX006.